Viewing Study NCT01723020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-03 @ 9:15 PM
Study NCT ID: NCT01723020
Status: COMPLETED
Last Update Posted: 2021-09-02
First Post: 2012-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
Sponsor: Kartos Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module